Opportunity Information: Apply for PA 07 032
Apply for PA 07 032
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "New Approaches to Arrhythmia Detection and Treatment (SBIR R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.837 Cardiovascular Diseases Research.
- This funding opportunity was created on Jan 26, 2009 and posted on Nov 3, 2006.
- Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses Others (see text field entitled Additional Information on Eligibility for clarification).
- Foreign institutions are not eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "New Approaches to Arrhythmia Detection and Treatment (SBIR R43/R44)" is a National Institutes of Health (NIH) funding announcement aimed at supporting small businesses that are developing new technologies or methods to improve how heart rhythm disorders (arrhythmias) are detected and treated. It uses the Small Business Innovation Research (SBIR) program mechanisms, specifically the R43/R44 formats, which are structured to help small companies move an idea from early feasibility work (Phase I) into more advanced development and validation (Phase II). The announcement also allows Fast Track applications, which are designed for projects that are ready to propose Phase I and Phase II as a single, linked submission in order to speed progress toward commercialization or broader clinical use.
A key point is that this SBIR announcement runs in parallel with a separate, scientifically identical announcement that uses the Small Business Technology Transfer (STTR) mechanisms (R41/R42), identified as PA 07 031. In practice, that means the scientific goals and topic area are the same across both announcements, but applicants choose the mechanism that best fits their collaboration model and eligibility details. SBIR generally emphasizes the small business as the primary R and D performer, while STTR formally requires a nonprofit research institution partner and a defined work split. This particular opportunity is specifically for SBIR applicants under PA 07 032.
The funding instrument type is a grant, and the activity category is health, tied to the NIH cardiovascular research portfolio. The Catalog of Federal Domestic Assistance (CFDA) listing associated with it is 93.837, Cardiovascular Diseases Research, which signals the programmatic home and broad subject area. There is no cost sharing or matching requirement stated, so applicants are not expected to provide matching funds as a condition of the award, which is typical for SBIR.
Eligibility is limited to United States small business concerns (SBCs). The announcement emphasizes that the business must meet all SBC criteria at the time of award for both Phase I and Phase II. While the text you provided references "Section III" for the full list of requirements, this generally means the applicant must qualify as a small business under SBIR rules, be for-profit, be based in the U.S., and meet ownership and size standards. The announcement is also explicit that foreign institutions are not eligible to apply, which is consistent with SBIR program requirements. The listing also notes "Others (see text field entitled Additional Information on Eligibility for clarification)," but the controlling statement remains that only eligible U.S. small business concerns can submit SBIR applications under this FOA.
In terms of timing and submission, the opportunity is listed as having multiple receipt dates rather than a single deadline, meaning NIH expected submissions across several standard due dates during the active period of the announcement. The posted date is November 3, 2006, with an archive date of January 5, 2010. The listing indicates that applicants should refer to the full announcement for the specific receipt dates and administrative details. Awards are described as contingent on two things: the availability of funds and the submission of a sufficient number of highly meritorious applications. In other words, even if a proposal is responsive, NIH will only make awards if appropriated funds are available and if the applications meet competitive scientific and technical standards in peer review.
For applicants looking for the authoritative requirements, the announcement provides a link to the full FOA on the NIH grants site (PA 07 032) and includes NIH Office of Extramural Research (OER) webmaster contact emails for technical access issues. The practical takeaway is that this is an NIH SBIR funding pathway for U.S. small businesses working on innovative arrhythmia detection and treatment solutions, with support available at early and later development stages and an option to accelerate progress through Fast Track when justified.
Frequently Asked Questions (FAQs): New Approaches to Arrhythmia Detection and Treatment (SBIR R43/R44)
1) What is the purpose of the "New Approaches to Arrhythmia Detection and Treatment (SBIR R43/R44)" opportunity?
This NIH funding announcement supports U.S. small businesses developing new technologies or methods to improve how heart rhythm disorders (arrhythmias) are detected and treated. The focus is on innovation that can move from feasibility to more advanced development and validation, with an eye toward commercialization or broader clinical use.
2) Which NIH small business program mechanism does this announcement use?
This opportunity uses the Small Business Innovation Research (SBIR) program mechanisms, specifically R43/R44, which correspond to Phase I (early feasibility) and Phase II (advanced development and validation).
3) What do Phase I (R43) and Phase II (R44) generally support in this announcement?
Phase I (R43) is structured to support early feasibility work. Phase II (R44) is structured to support more advanced development and validation efforts that build on Phase I results.
4) Does this announcement allow Fast Track applications?
Yes. Fast Track applications are allowed, meaning an applicant may propose Phase I and Phase II as a single, linked submission when the project is ready for that accelerated approach.
5) What is the advantage of using the Fast Track option under this FOA?
The Fast Track option is designed to speed progress by letting applicants submit a combined Phase I/Phase II plan in one application, which can help move a ready project toward commercialization or broader clinical use more quickly.
6) Is there a related STTR announcement with the same scientific topic?
Yes. This SBIR announcement runs in parallel with a separate, scientifically identical announcement using the Small Business Technology Transfer (STTR) mechanisms (R41/R42), identified as PA 07 031.
7) If the SBIR and STTR announcements are scientifically identical, why are there two different opportunities?
They use different small business mechanisms and collaboration structures. Applicants choose the mechanism that fits their eligibility and partnership model. The SBIR version (this opportunity) generally emphasizes the small business as the primary R&D performer, while STTR formally requires a nonprofit research institution partner and a defined work split.
8) Which specific FOA is this FAQ describing?
This FAQ describes the SBIR funding announcement identified as PA 07 032 (R43/R44). The STTR counterpart is PA 07 031 (R41/R42).
9) What is the funding instrument type for this opportunity?
The funding instrument type is a grant.
10) What is the activity category or subject area for this announcement?
The activity category is health, within NIH's cardiovascular research portfolio, specifically focused on arrhythmia detection and treatment innovation.
11) What CFDA number is associated with this opportunity and what does it indicate?
The CFDA listing is 93.837, Cardiovascular Diseases Research. This indicates the programmatic home and broad subject area for the opportunity.
12) Is cost sharing or matching required?
No cost sharing or matching requirement is stated. Applicants are not expected to provide matching funds as a condition of the award, which is typical for SBIR.
13) Who is eligible to apply?
Eligibility is limited to United States small business concerns (SBCs). The business must meet all SBC criteria at the time of award for both Phase I and Phase II.
14) Are foreign institutions eligible to apply?
No. The announcement is explicit that foreign institutions are not eligible to apply, consistent with SBIR program requirements.
15) When must a company meet SBIR small business concern (SBC) eligibility requirements?
The announcement emphasizes that the business must meet all SBC criteria at the time of award for both Phase I and Phase II.
16) Does this opportunity have a single deadline?
No. It is listed as having multiple receipt dates rather than a single deadline, meaning NIH expected submissions across several standard due dates during the active period of the announcement.
17) Where should applicants find the specific due dates and administrative submission details?
Applicants are directed to refer to the full announcement on the NIH grants site (PA 07 032) for the specific receipt dates and administrative requirements.
18) What are the posted date and archive date shown for this opportunity?
The posted date is November 3, 2006, and the archive date is January 5, 2010.
19) Are awards guaranteed if an application is responsive to the topic?
No. Awards are described as contingent on the availability of funds and the submission of a sufficient number of highly meritorious applications, meaning applications must be competitive in peer review and funding must be available.
20) Where can applicants get help if they have trouble accessing the FOA online?
The announcement includes NIH Office of Extramural Research (OER) webmaster contact emails for technical access issues, and also provides a link to the full FOA on the NIH grants site.
Browse more opportunities from the same category: Health
Next opportunity: Image Guided Cancer Interventions (STTR R41/R42)
Previous opportunity: New Approaches to Arrhythmia Detection and Treatment (STTR R41/R42)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 07 032
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 07 032) also looked into and applied for these:
| Funding Opportunity |
|---|
| Collaborative R01s for Clinical and Services Studies of Mental Disorders, AIDS and Alcohol Use Disorders (R01) Apply for PA 07 092 Funding Number: PA 07 092 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advanced Tools and Technologies for Deep Brain Stimulation in Movement Disorders STTR (R41/R42) Apply for PA 07 395 Funding Number: PA 07 395 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Computational Tools for Research in Neuroscience, Behavioral Science and Mental Health STTR R41/R42 Apply for PA 07 423 Funding Number: PA 07 423 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Computational Tools for Research in Neuroscience, Behavioral Science and Mental Health SBIR R43/R44 Apply for PA 07 424 Funding Number: PA 07 424 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Technology for Proteomics and Glycomics (SBIR R43/R44) Apply for PA 07 451 Funding Number: PA 07 451 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Technology for Proteomics and Glycomics (STTR R41/R42) Apply for PA 07 452 Funding Number: PA 07 452 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High Throughput Tools for Brain and Behavior (SBIR R43/R44) Apply for PA 08 001 Funding Number: PA 08 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High Throughput Tools for Brain and Behavior (STTR R41/R42) Apply for PA 08 002 Funding Number: PA 08 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of PET and SPECT Ligands for Brain Imaging (SBIR R43/R44) Apply for PA 08 137 Funding Number: PA 08 137 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pharmacologic Agents and Drugs for Mental Disorders (SBIR R43/R44) Apply for PA 08 142 Funding Number: PA 08 142 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Cooperative Program in Translational Research Small Business Awards (SBIR U44) Apply for PAR 08 235 Funding Number: PAR 08 235 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| State Implementation Grants for Integrated Community Systems for CSHCN Apply for HRSA 09 159 Funding Number: HRSA 09 159 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Part D Coordinated HIV Services and Access to Research for WICY One TimeSupplemental Funds Apply for HRSA 09 143 Funding Number: HRSA 09 143 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Development, Implementation and Evaluation of Strategies to Increase Vaccination of Adolescents Affiliated with a Medical Home (U01) Apply for RFA IP 09 006 Funding Number: RFA IP 09 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| Evaluation of New Technology to Improve Delivery of Immunizations (U01) Apply for RFA IP 09 005 Funding Number: RFA IP 09 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $225,000 |
| NCMHD Endowment Program for Increasing Research and Institutional Resources Capacity in Section 736 Health Professions Schools (NCMHD Research Endowment Fund) (S21) Apply for RFA MD 09 002 Funding Number: RFA MD 09 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Extension of the World Trade Center Registry (U50) Apply for RFA OH 09 002 Funding Number: RFA OH 09 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $12,000,000 |
| NCMHD Research Infrastructure in Minority Institutions (P20) Apply for RFA MD 09 003 Funding Number: RFA MD 09 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Community Based HIV/AIDS Prevention, Care and Support Apply for USAID UGANDA RFA 617 09 005 Funding Number: USAID UGANDA RFA 617 09 005 Agency: Agency for International Development Category: Health Funding Amount: $22,000,000 |
| Pre Application for Dietary Supplement Research Centers Botanicals (X02) Apply for PAR 09 091 Funding Number: PAR 09 091 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 032", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.